Long-term follow-up of ribavirin-free DAA-based treatment in HCV recurrence after orthotopic liver transplantation.

Sandra BeinhardtRamona Al-ZoairyKarin KozbialAlbert F StättermayerAndreas MaieronRudolf StauberMichael StrasserHeinz ZollerIvo GraziadeiSusanne Rasoul-RockenschaubMichael TraunerPeter FerenciHarald Hofer

Published in: Liver international : official journal of the International Association for the Study of the Liver (2018)

RBV-free DAA combinations for the treatment of HCV recurrence after OLT are highly efficacious and well tolerated. Our long-term data show that viral eradication is durable but not necessarily translated into beneficial long-term clinical outcome.

Keyphrases

hepatitis c virus
sars cov
machine learning
combination therapy
helicobacter pylori
hiv infected
replacement therapy